• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Mast Therapeutics Inc

+ Add to Watchlist

YB4N:GR

0.366 EUR 0.017 4.87%

As of 15:14:48 ET on 12/23/2014.

Snapshot for Mast Therapeutics Inc (YB4N)

Open: 0.354 Day's Range: 0.331 - 0.374 Volume: 0
Previous Close: 0.349 52wk Range: 0.281 - 1.010 1-Yr Rtn: +30.25%

Stock Chart for YB4N

No chart data available.
  • YB4N:GR 0.335
  • 1D
  • 1M
  • 1Y
0.349
Interactive YB4N Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for YB4N

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2300
Est. PEG Ratio -
Market Cap (M EUR) 58.36
Shares Outstanding (M) 159.46
30 Day Average Volume 557
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for YB4N

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for YB4N

Mast Therapeutics Inc. is a biopharmaceutical company leveraging the MAST (Molecular Adhesion and Sealant Technology) platform, derived from clinical, nonclinical and manufacturing experience with purified and non-purified poloxamers for serious or life-threatening diseases with significant unmet needs.

Brian M CulleyChief Executive OfficerPatrick L Keran "Pat"President/COO
Brandi L RobertsSenior VP/CFOEdwin L Parsley "Ed"Senior VP/Chief Medical Ofcr
More Company Profile & Key Executives for YB4N

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil